Editorial: The New Trial EMPAREG-OUTCOMES in Type 2 Diabetes: "and Death Shall Have no Dominion"?

Editorial: The New Trial EMPAREG-OUTCOMES in Type 2 Diabetes: "and Death Shall Have no Dominion"? Curr Vasc Pharmacol. 2016 Feb 29; Authors: Papanas N, Tsioufis C, Maltezos E PMID: 26924324 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/26924324?dopt=Abstract

Source: Current Vascular Pharmacology - February 29, 2016 Category: Drugs & Pharmacology Authors: Papanas N, Tsioufis C, Maltezos E Tags: Curr Vasc Pharmacol Source Type: research

More News: Diabetes | Diabetes Type 2 | Drugs & Pharmacology | Endocrinology